What This CT Finding Means
This finding is almost certainly benign and requires no immediate action—the radiologist is telling you they saw something too small and faint to definitively characterize, but it's most likely either a tiny hemangioma or simply an imaging artifact (volume averaging), not a true lesion at all.
Understanding the Terminology
The report describes three key features that all point toward a benign, clinically insignificant finding:
- "Subcentimeter": The lesion is less than 1 cm in size
- "Hypodense focus": It appears slightly darker than surrounding liver tissue
- "Faintly visualized": It's barely visible, suggesting it may not be a real lesion
- "Not convincingly seen on delayed phase": When contrast redistributes later in the scan, the finding essentially disappears
Why This Is Reassuring
CT resolution fundamentally cannot definitively characterize lesions smaller than 1 cm 1. This is a well-established technical limitation, not a failure of the scan or radiologist.
The critical evidence supporting a benign interpretation:
- 78-84% of small hypodense liver lesions in patients with known cancer are benign 1
- The fact that it disappears on delayed imaging strongly suggests it's either:
- Volume averaging (pixels averaging tissue densities at the edge of structures, creating a false appearance of a lesion)
- An artifact from breathing or motion
- A tiny hemangioma too small to characterize
What About Hemangiomas?
Hemangiomas are the most common benign liver tumors. When subcentimeter in size, they often appear as small hypodense foci that may not show typical enhancement patterns because they're simply too small for the CT to resolve their characteristic features 2, 3. This is completely normal behavior for tiny hemangiomas and does not indicate anything concerning.
Clinical Context Matters
Your risk stratification depends entirely on:
- No history of cancer: If you have no malignancy history, this finding is almost certainly benign and can be ignored
- History of cancer: Even with cancer history, 78-84% of these lesions remain benign 1
- Multiple risk factors for liver disease: This would be the only scenario requiring closer attention
What Happens Next
For patients without cancer history or high-risk liver disease: No follow-up imaging is needed 1.
For patients with known malignancy: The decision tree is:
- If clinically stable with no other concerning findings → routine surveillance per your oncology protocol
- If multiple new liver lesions or clinical deterioration → consider MRI with gadoxetate contrast, which has 92-93% accuracy for differentiating benign from malignant subcentimeter lesions using ADC values 1
- Do NOT pursue: Repeat CT (won't add information), PET scan (insufficient sensitivity for <1 cm lesions), or biopsy (technically difficult and unnecessary) 1
Common Pitfalls to Avoid
- Don't over-investigate: The temptation to "rule out" something this small leads to unnecessary testing, cost, and patient anxiety
- Don't assume malignancy: The default assumption for subcentimeter hypodense foci should be benign, not cancer
- Don't repeat the same test: Another CT won't provide better characterization—if anything is needed, it's MRI, not more CT
The Bottom Line
This is radiologist-speak for "I saw something that's probably nothing, but I'm documenting it to be thorough." The combination of subcentimeter size, faint visualization, and disappearance on delayed imaging makes this an incidental finding of no clinical significance in the vast majority of cases. Unless you have active cancer with other concerning features, this can be safely ignored.